Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: Evidence for a concentration-dependent defect in uptake

Diabetes

Volumn 47, Issue 11, 1998, Pages 1735-1747

  Nielsen, Michael F ^b   Basu, Rita ^a   Wise, Steven ^a   Caumo, Andrea ^c   Cobelli, Claudio ^d   Rizza, Robert A ^a  

^a MAYO CLINIC   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

BLOOD GLUCOSE; C-PEPTIDE; CARBON DIOXIDE; CARBON RADIOISOTOPES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLYCOSURIA; HUMAN GROWTH HORMONE; HUMANS; INSULIN; KINETICS; MALE; MIDDLE AGED; TRITIUM;

EID: 0031719659     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.11.1735     Document Type: Article

References (70)

1. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA: Postprandial hyperglycemia in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 77:1525-1532, 1986
2. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, Gerich J: Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39:1381-1390, 1990
3. Ferrannini E, Simonson DC, Katz LD, Reichard G Jr, Bevilacqua S, Barrett EJ, Olsson M, DeFronzo RA: The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 37:79-85, 1988
4. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J: Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32:35-45, 1983
5. Ader M, Ni T, Bergman RN: Glucose effectiveness assessed under dynamic and steady-state conditions. J Clin Invest 99:1187-1199, 1997
6. Yki-Jarvinen H, Young AA, Lamkin C, Foley JE: Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 79:1713-1719, 1987
7. Rossetti L, Giaccari A, Barzilai N, Howard K, Sebel G, Hu M: Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. J Clin Invest 92:1126-1134, 1993
8. Rizza RA, Mandarino LJ, Gerich JE: Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240:E630-E639, 1981
9. Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM: Receptor and postreceptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J Clin Invest 68:957-969, 1981
10. Firth R, Bell P, Rizza R: Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. Metabolism 36:1091-1095, 1987
11. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D: Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and non-insulin-dependent diabetic subjects. J Clin Invest 74:1238-1246, 1984
12. Firth RG, Bell PM, Rizza RA: Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 314:1280-1286, 1986
13. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
14. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Naga I, Tokuyama K: Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41:1540-1546, 1992
15. Wajchenberg BL, Santomauro ATMG, Porrelli RN: Effect of a sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose-mediated glucose disposal in patients with non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Res Clin Pract 20:147-154, 1993
16. Welch S, Gebhart SSP, Bergman RN, Phillips LS: Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71:1508-1518, 1990
17. Davis SN, Monti L, Piatti PM, Moller N, Ng L, Coppack S, Brown MD, Orskov H, Alberti KG: Estimates of insulin action in normal, obese, and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model, and glucose clamp techniques. Diabetes Res 23:1-18, 1993
18. Kruszynska YT, Harry DS, Bergman RN, McIntyre N: Insulin sensitivity, insulin secretion, and glucose effectiveness in diabetic and nondiabetic cirrhotic patients. Diabetologia 36:121-128, 1993
19. Quon MJ, Cochran C, Taylor SI, Eastman RC: Non-insulin-mediated glucose disappearance in subjects with IDDM. Diabetes 43:890-896, 1994
20. Caumo A, Vicini P, Cobelli C: Is minimal model too minimal? Diabetologia 39:997-1000, 1996
21. Finegood DT, Tzur D: Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method. Am J Physiol 271:E485-E495, 1996
22. Alzaid AA, Dinneen SF, Turk DJ, Caumo A, Cobelli C, Rizza RA: Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J Clin Invest 94:2341-2348, 1994
23. Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C: unpaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes 46:421-432, 1997
24. Del Prato S, Matsuda M, Simonson DC, Groop LC, Sheehan P, Leonetti F, Bonadonna RC, DeFronzo RA: Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia 40:687-697, 1997
25. Avogaro A, Vicini P, Valerio A, Caumo A, Cobelli C: The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects. Am J Physiol 270:E532-E540, 1996
26. White NH, Skor D, Santiago JV: Practical closed-loop insulin delivery: a system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med 97:210-213, 1982
27. Finegood DT, Bergman RN, Vranic M: Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37:1025-1034, 1988
28. McMahon M, Marsh HM, Rizza RA: Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM. Diabetes 38:291-303, 1989
29. 3H]glucose. J Clin Invest 78:1479-1486, 1986
30. Jensen MD, Kanaley JA, Reed JE, Sheedy PF: Measurement of abdominal and visceral fat with computed tomography and dual-energy X-ray absorptiometry. Am J Clin Nutr 61:274-278, 1995
31. Bradley DC, Steil GM, Bergman RN: Quantitation of measurement error with optimal segments: basis for adaptive time course smoothing. Am J Physiol 264:E902-E911, 1993
32. Steele R, Wall JS, De Bodo RC, Altszuler N, Kiang SP, Bjerknes C: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
33. Caumo A, Homan M, Katz H, Cobelli C, Rizza R: Glucose turnover in presence of changing glucose concentrations: error analysis for glucose disappearance. Am J Physiol 269:E557-E567, 1995
34. Butler PC, Caumo A, Zerman A, O'Brien PC, Cobelli C, Rizza RA: Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol 264:E548-E569, 1993
35. Katz J, Rognstad R: Futile cycles in the metabolism of glucose. Curr Top Cell Regul 10:237-289, 1976
36. Efendic S, Wajngot A, Vranic M: Increased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes. Proc Natl Acad Sci U S A 82:2965-2969, 1985
37. Butler RC, Rizza RA: Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes 40:73-81, 1991
38. Sacca L, Hendler R, Sherwin RS: Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. J Clin Endocrinol Metab 47:1160-1161, 1978
39. 14C]glucose during hyperinsulinemia in humans. Diabetes 38:97-107, 1989
40. Davidson MB: Autoregulation by glucose of hepatic balance: permissive effect of insulin. Metabolism 30:279-284, 1981
41. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29, 1992
42. Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M, DeFronzo RA: In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension. Diabetes 42:764-772, 1993
43. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS: Intensive conventional insulin therapy for type II diabetes. Diabetes Care 16:21-31, 1993
44. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI: Increased rate of gluconeogenesis in type II diabetes mellitus. J Clin Invest 90:1323-1327, 1992
45. Wajngot A, Chandramouli V, Schumann WC, Kumaran K, Efendic S, Landau BR: Testing of the assumptions made in estimating the extent of futile cycling. Am J Physiol 256:E668-E675, 1989
46. Massillon D, Barzilai N, Chen W, Hu M, Rossetti L: Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem 271:9871-9874, 1996
47. Consoli A, Nurjhan N, Capani F, Gerich J: Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38:550-557, 1989
48. Yki-Järvinen H, Helve E, Sane T, Nurjhan N, Taskinen M: Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM. Am J Physiol 256:E732-E739, 1989
49. Brosnan JT: Pathways of carbon flux in gluconeogeneis. Fed Proc 41:91-94, 1982
50. 14C-labeled substrates. Am J Physiol 17:391-399, 1985
51. 2 in estimating rates of hepatic gluconeogenesis. Am J Physiol 263:E36-E41, 1992
52. Turk D, Alzaid A, Dinneen S, Nair KS, Rizza R: The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest 95:755-762, 1995
53. Mandarino LJ, Consoli A, Jain A, Kelley DE: Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol 270:E463-E470, 1996
54. Baron AD, Kolterman OG, Bell J, Mandarino LJ, Olefsky JM: Rates of non-insulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest 76:1782-1788, 1985
55. Capaldo B, Santoro D, Riccardi G, Perrotti N, Sacca L: Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type II diabetes. J Clin Invest 77:1285-1290, 1986
56. Bonadonna RC, Del Prato S, Bonora E, Saccomani MP, Guilli G, Natali A, Frascerra S, Pecori N, Ferrannini E, Bier D, Cobelli C, DeFronzo RA: Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45:915-925, 1996
57. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. J Clin Invest 89:1069-1075, 1992
58. Katz H, Butler P, Homan M, Zerman A, Caumo A, Cobelli C, Rizza R: Hepatic and extrahepatic insulin action in humans: measurement in the absence of non-steady-state error. Am J Physiol 264:E561-E566, 1993
59. Ferrannini E, Locatelli L, Jequier E, Felber JP: Differential effects of insulin and hyperglycemia on intracellular glucose disposition in humans. Metabolism 38:459-465, 1989
60. Ronan R, Velho G, Carlier PG, Jouvensal L, Bloch G: In vivo NMR evidence for moderate glucose accumulation in human skeletal muscle during hyperglycemia. Am J Physiol 271:E434-E438, 1996
61. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
62. Henry RR, Gumbiner B, Flynn T, Thorburn AW: Metabolic effects of hyperglycemia and hyperinsulinemia on fat of intracellular glucose in NIDDM. Diabetes 39:149-156, 1990
63. Vaag A, Damsbo P, Hother-Nielsen O, Beck-Nielsen H: Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:80-88, 1992
64. Kelley DE, Mandarino LJ: Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in non-insulin-dependent diabetes mellitus. J Clin Invest 86:1999-2007, 1990
65. Wise SD, Nielsen MF, Cryer PE, Rizza RA: Overnight normalization of glucose concentrations improves hepatic but not extrahepatic insulin action in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 83:2461-2469, 1998
66. Katz H, Homan M, Velosa J, Robertson P, Rizza R: Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 325:1278-1283, 1991
67. Bradley DC, Poulin RA, Bergman RN: Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes 42:296-306, 1993
68. Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HLA, Vranic M: Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90:1769-1777, 1992
69. Neese RA, Schwarz J, Faix D, Turner S, Letscher A, Vu D, Hellerstein MK: Gluconeogenesis and intrahepatic those phosphate flux in response to fasting or substrate loads. J Biol Chem 270:14452-14463, 1995
70. 13C-labeled lactate. J Biol Chem 268:25509-25521, 1993